Walgreens Concludes Public Trading Era with Landmark Private Equity Acquisition

The chapter closes on Walgreens Boots Alliance’s nearly 98-year history as a publicly traded entity, following the finalization of its acquisition by private equity firm Sycamore Partners. The transaction, valued at up to $23.7 billion including assumed debt, signifies a pivotal transformation for the struggling pharmacy operator.

Shareholders will receive $11.45 per share in cash, along with potential future claims of up to an additional $3 per share tied to the eventual disposition of VillageMD assets. The company’s stock has been officially delisted from the Nasdaq exchange effective immediately.

Sycamore Partners has moved swiftly to implement sweeping changes, commencing with a leadership transition. Mike Motz, the former CEO of Staples US Retail, has been appointed to lead Walgreens without delay.... Read more...